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Abstract 
Drug abuse is a worldwide issue which has led to an increasing need for on-site testing. 
Current on-site tests for illicit drugs are immunostrip devices which only test for a select 
number of analytes and require confirmatory laboratory testing. Raman spectroscopy is 
a non-destructive technique which when coupled with more sensitive Raman methods, 
such as surface-enhanced Raman spectroscopy (SERS), could allow for this technique 
to be used for the detection of illicit drugs at lower levels. This study investigated the 
development and use of SERS for the analysis of illicit drugs in oral fluid.  
The first aim of the study was to benchmark commercially available SERS substrates 
for the analysis of illicit drugs. Seven commercially available SERS substrates were 
tested, and the substrate which enhanced the most analyte bands consistently was the 
JASMAT Ag substrate. The JASMAT Ag substrate was tested with several illicit drugs 
and their metabolites both as standards and extracted from oral fluid. All of the analytes, 
except THC, were able to be detected down to at least 10 ng/mL in standard solutions. 
The analytes extracted from oral fluid showed less analyte specific bands.  
The second aim of the study was to use SERS for the quantification of 
methylamphetamine in oral fluid solutions. Two quantification methods were trialled for 
quantification; calibration curves using peak intensity and partial least squares 
regression (PLS). The PLS quantification attempts with oral fluid extraction samples 
revealed a negative interaction between the organic solvent and the JASMAT Ag SERS 
substrate. This resulted in an alternative pillar cuvette extraction method being trialled. 
The pillar cuvettes allowed for the tentative detection of methylamphetamine at a 
concentration of 100 ng/mL.  
The third aim of the study was to develop a SERS substrate which was reproducible, 
cheap and able to enhance the analyte bands to the standard of the best performing 
commercial substrate. Many methods of SERS development were attempted, however, 
the only method which produced a reliable SERS substrate for illicit drug analysis was 
the plasma printing method. The 6 pass plasma printed substrate enhanced a similar 
number of bands to the JASMAT Ag substrate in the analysis of cocaine and fentanyl. 
Abstract 
~ xxxi ~ 
In conclusion, SERS has been shown to be a promising technology for the analysis of 
illicit drugs in oral fluid. This research has built foundations for the future development 
of an on-site collection, extraction and SERS device for oral fluid analysis of illicit 
drugs.
